Geneva group lauds move on cheaper hep C drug


  • Nation
  • Friday, 22 Sep 2017

PETALING JAYA: Malaysia’s landmark decision to invoke a “government-use” licence to get access to affordable versions of a hepatitis C drug will have a major impact on global efforts to open up expensive treatments to more people, the Geneva-based Drugs for Neglected Diseases initiative (DNDi) said.

This should give 400,000 people living with hepatitis C in Malaysia access to sofosbuvir, DNDi executive director Dr Bernard Pécoul said in a statement on Wednesday.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Nation

Penang building collapse: One confirmed dead, two others injured
The logging activities in Sipitang are legal, says Sabah Forestry Dept
Sarawak contributed greatly in ensuring nation's political stability, says Anwar
Muslim countries must work together to spur their development, says Anwar
Nine workers feared dead after building collapse in Penang
I was just responding to Aman Palestin, Azam tells lawyer
Anwar, Indonesian vice-president to deliver keynote address at GMBF 2023
Underage marriages: 533 couples recorded in Kelantan since 2019
Perak MB to present state Budget this Friday
Posting of auxiliary police has not reached 50%, says Bukit Aman

Others Also Read